The Role of Serotonin in Depression

Handbook of Behavioral Neuroscience

Volumn 21, Issue C, 2010, Pages 493-505

  Carr, Gregory V ^a   Lucki, Irwin ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

antidepressants; depression; knockout mice; models of depression; psychiatry; rat; serotonin; SSRIs

Indexed keywords

EID: 85013799208     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1569-7339(10)70098-9     Document Type: Chapter

References (131)

1. 2A receptors Eur. J. Pharmacol. 261 1994 285 294
2. J.P. Anthony T.J. Sexton J.F. Neumaier Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation J. Neurosci. Res. 61 2000 82 87
3. V. Arango M.D. Underwood J.J. Mann Serotonin brain circuits involved in major depression and suicide Prog. Brain Res. 136 2002 443 453
4. F. Artigas L. Romero C. de Montigny P. Blier Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists Trends Neurosci. 19 1996 378 383
5. M. Asberg Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies, Ann. N. Y. Acad. Sci. 836 1997 158 181
6. M. Banasr M. Hery R. Printemps A. Daszuta Serotonin-induced increases in adult cell proliferation and neurogenesis are mediated through different and common 5-HT receptor subtypes in the dentate gyrus and the subventricular zone Neuropsychopharmacology 29 2004 450 460
7. N.M. Barnes T. Sharp A review of central 5-HT receptors and their function Neuropharmacology 38 1999 1083 1152
8. J.M. Beaulieu X. Zhang R.M. Rodriguiz T.D. Sotnikova M.J. Cools W.C. Wetsel R.R. Gainetdinov M.G. Caron Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency Proc. Natl. Acad. Sci. USA 105 2008 1333 1338
9. Z. Bhagwagar E.A. Rabiner P.A. Sargent P.M. Grasby P.J. Cowen Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 Mol. Psychiatry 9 2004 386 392
10. Z. Bhagwagar R. Hinz M. Taylor S. Fancy P. Cowen P. Grasby Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907 Am. J. Psychiatry 163 2006 1580 1587
11. Z. Bhagwagar N. Murthy S. Selvaraj R. Hinz M. Taylor S. Fancy P. Grasby P. Cowen 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB Am. J. Psychiatry 164 2007 1858 1865
12. 3 receptor differentially affects behavior of males and females in the Porsolt forced swim and defensive withdrawal tests Behav. Brain Res. 153 2004 527 535
13. P. Blier N.M. Ward Is there a role for 5-HT1A agonists in the treatment of depression? Biol. Psychiatry 53 2003 193 203
14. S.R. Bodnoff B. Suranyi-Cadotte D.H. Aitken R. Quirion M.J. Meaney The effects of chronic antidepressant treatment in an animal model of anxiety Psychopharmacology (Berl.) 95 1988 298 302
15. P. Bonaventure L. Kelly L. Aluisio J. Shelton B. Lord R. Galici K. Miller J. Atack T.W. Lovenberg C. Dugovic Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents J. Pharmacol. Exp. Ther. 321 2007 690 698
16. M. Bourin E. Mocaer R. Porsolt Antidepressant-like activity of S 20098 (agomelatine) in the forced swimming test in rodents: involvement of melatonin and serotonin receptors J. Psychiatry Neurosci. 29 2004 126 133
17. 3 receptor antagonist, tropisetron, reduces immobility in intact female rats exposed to the forced swim test Pharmacol. Biochem. Behav. 85 2006 362 368
18. 2A receptor expression Neuroreport 6 1995 901 904
19. D.M. Cannon M. Ichise D. Rollis J.M. Klaver S.K. Gandhi D.S. Charney H.K. Manji W.C. Drevets Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder Biol. Psychiatry 62 2007 870 877
20. L. Cervo G. Grignaschi E. Nowakowska R. Samanin 1-(3-Trifluoromethylphenyl) piperazine (TFMPP) in the ventral tegmental area reduces the effect of desipramine in the forced swimming test in rats: possible role of serotonin receptors Eur. J. Pharmacol. 171 1989 119 125
21. R. Cesana A. Ceci C. Ciprandi F. Borsini Mesulergine antagonism towards the fluoxetine anti-immobility effect in the forced swimming test in mice J. Pharm. Pharmacol. 45 1993 473 475
22. J.M. Chou-Green T.D. Holscher M.F. Dallman S.F. Akana Repeated stress in young and old 5-HT(2C) receptor knockout mice Physiol. Behav. 79 2003 217 226
23. F. Clenet A. De Vos M. Bourin Involvement of 5-HT(2C) receptors in the anti-immobility effects of antidepressants in the forced swimming test in mice Eur. Neuropsychopharmacol. 11 2001 145 152
24. V. Compan M. Zhou R. Grailhe R.A. Gazzara R. Martin J. Gingrich A. Dumuis D. Brunner J. Bockaert R. Hen Attenuated response to stress and novelty and hypersensitivity to seizures in 5-HT4 receptor knockout mice J. Neurosci. 24 2004 412 419
25. G. Conductier N. Dusticier G. Lucas F. Cote G. Debonnel A. Daszuta A. Dumuis A. Nieoullon R. Hen J. Bockaert V. Compan Adaptive changes in serotonin neurons of the raphe nuclei in 5-HT(4) receptor knockout mouse Eur. J. Neurosci. 24 2006 1053 1062
26. P.J. Cowen M. Parry-Billings E.A. Newsholme Decreased plasma tryptophan levels in major depression J. Affect. Disord. 16 1989 27 31
27. J.F. Cryan I. Lucki Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors J. Pharmacol. Exp. Ther. 295 2000 1120 1126
28. J.F. Cryan D.A. Slattery Animal models of mood disorders: recent developments Curr. Opin. Psychiatry 20 2007 1 7
29. J.F. Cryan A.M. Redmond J.P. Kelly B.E. Leonard The effects of the 5-HT1A agonist flesinoxan, in three paradigms for assessing antidepressant potential in the rat Eur. Neuropsychopharmacol. 7 1997 109 114
30. J.F. Cryan R.J. Valentino I. Lucki Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test Neurosci. Biobehav. Rev. 29 2005 547 569
31. 1B receptor antagonist SB-616234-A (1-[6-(cis-3,5-dimethylpiperazin-1-yl)-2,3-dihydro-5-methoxyindol-1-yl]-1- [2′-methyl-4′ -(5-methyl-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methanone hydrochloride): in vivo neurochemical and behavioural evidence of anxiolytic/antidepressant activity Neuropharmacology 50 2006 975 983
32. 2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models Psychopharmacology (Berl.) 199 2008 549 568
33. P.L. Delgado How antidepressants help depression: mechanisms of action and clinical response J. Clin. Psychiatry 65 Suppl 4 2004 25 30
34. P.L. Delgado L.H. Price H.L. Miller R.M. Salomon J. Licinio J.H. Krystal G.R. Heninger D.S. Charney Rapid serotonin depletion as a provocative challenge test for patients with major depression: relevance to antidepressant action and the neurobiology of depression Psychopharmacol. Bull. 27 1991 321 330
35. P.L. Delgado H.L. Miller R.M. Salomon J. Licinio J.H. Krystal F.A. Moreno G.R. Heninger D.S. Charney Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action Biol. Psychiatry 46 1999 212 220
36. M.J. Detke M. Rickels I. Lucki Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants Psychopharmacology (Berl.) 121 1995 66 72
37. M.J. Detke S. Wieland I. Lucki Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists Psychopharmacology (Berl.) 119 1995 47 54
38. J. De Vry 5-HT1A receptor agonists: recent developments and controversial issues Psychopharmacology (Berl.) 121 1995 1 26
39. W.C. Drevets M.E. Thase E.L. Moses-Kolko J. Price E. Frank D.J. Kupfer C. Mathis Serotonin-1A receptor imaging in recurrent depression: replication and literature review Nucl. Med. Biol. 34 2007 865 877
40. S.C. Dulawa K.A. Holick B. Gundersen R. Hen Effects of chronic fluoxetine in animal models of anxiety and depression Neuropsychopharmacology 29 2004 1321 1330
41. S.C. Dulawa R. Hen Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test Neurosci. Biobehav. Rev. 29 2005 771 783
42. E. Edwards K. Harkins G. Wright F.A. Henn 5-HT1b receptors in an animal model of depression Neuropharmacology 30 1991 101 105
43. B. Eisensamer G. Rammes G. Gimpl M. Shapa U. Ferrari G. Hapfelmeier B. Bondy C. Parsons K. Gilling W. Zieglgansberger F. Holsboer R. Rupprecht Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor Mol. Psychiatry 8 2003 994 1007
44. V. Fabre C. Beaufour A. Evrard A. Rioux N. Hanoun K.P. Lesch D.L. Murphy L. Lanfumey M. Hamon M.P. Martres Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knockout mice lacking the 5-HT transporter Eur. J. Neurosci. 12 2000 2299 2310
45. E.C. Gavioli C.W. Vaughan G. Marzola R. Guerrini V.A. Mitchell S. Zucchini T.C. De Lima G.A. Rae S. Salvadori D. Regoli G. Calo Antidepressant-like effects of the nociceptin/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice Naunyn. Schmiedebergs Arch. Pharmacol. 369 2004 547 553
46. C.E. Glatt E. Carlson T.R. Taylor N. Risch V.I. Reus C.A. Schaefer Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 Neuron 48: 704-705; author reply 705-706
47. G. Gobbi D.L. Murphy K. Lesch P. Blier Modifications of the serotonergic system in mice lacking serotonin transporters: an)n vivo electrophysiological study J. Pharmacol. Exp. Ther. 296 2001 987 995
48. C. Gross X. Zhuang K. Stark S. Ramboz R. Oosting L. Kirby L. Santarelli S. Beck R. Hen Serotonin1A receptor acts during development to establish normal anxietylike behaviour in the adult Nature 416 2002 396 400
49. E. Gur B. Lerer E. Dremencov M.E. Newman Chronic repetitive transcranial magnetic stimulation induces subsensitivity of presynaptic serotonergic autoreceptor activity in rat brain Neuroreport 11 2000 2925 2929
50. M. Guscott L.J. Bristow K. Hadingham T.W. Rosahl M.S. Beer J.A. Stanton F. Bromidge A.P. Owens I. Huscroft J. Myers N.M. Rupniak S. Patel P.J. Whiting P.H. Hutson K.C. Fone S.M. Biello J.J. Kulagowski G. McAllister Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression Neuropharmacology 48 2005 492 502
51. N. Haddjeri P. Blier C. de Montigny Long-term antidepressant treatments result in a tonic activation of forebrain 5-HT1A receptors J. Neurosci. 18 1998 10150 10156
52. P.B. Hedlund S. Huitron-Resendiz S.J. Henriksen J.G. Sutcliffe 5-HT7 receptor inhibition and inactivation induce antidepressantlike behavior and sleep pattern Biol. Psychiatry 58 2005 831 837
53. L.K. Heisler H.M. Chu T.J. Brennan J.A. Danao P. Bajwa L.H. Parsons L.H. Tecott Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice Proc. Natl. Acad. Sci. USA 95 1998 15049 15054
54. L.K. Heisler L. Zhou P. Bajwa J. Hsu L.H. Tecott Serotonin 5-HT(2C) receptors regulate anxiety-like behavior Genes Brain Behav. 6 2007 491 496
55. J. Hirvonen H. Karlsson J. Kajander A. Lepola J. Markkula H. Rasi-Hakala K. Nagren J.K. Salminen J. Hietala Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635 Int. J. Neuropsychopharmacol. 11 2008 465 476
56. S. Hogg A. Dalvi Acceleration of onset of action in schedule-induced polydipsia: combinations of SSRI and 5-HT1A and 5-HT1B receptor antagonists Pharmacol. Biochem. Behav. 77 2004 69 75
57. A. Holmes R.J. Yang D.L. Murphy J.N. Crawley Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter Neuropsychopharmacology 27 2002 914 923
58. L.A. Jans W.J. Riedel C.R. Markus A. Blokland Serotonergic vulnerability and depression: assumptions, experimental evidence and implications Mol. Psychiatry 12 2006 522 543
59. L.A. Jans W.J. Riedel C.R. Markus A. Blokland Serotonergic vulnerability and depression: assumptions, experimental evidence and implications Mol. Psychiatry 12 2007 522 543
60. J. Jarosik B. Legutko K. Unsicker von Bohlen O. Und Halbach Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy Exp. Neurol. 204 2007 20 28
61. M.N. Jayatissa C. Bisgaard A. Tingstrom M. Papp O. Wiborg Hippocampal cytogenesis correlates to escitalopram-mediated recovery in a chronic mild stress rat model of depression Neuropsychopharmacology 31 2006 2395 2404
62. M.D. Jones I. Lucki Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice Neuropsychopharmacology 30 2005 1039 1047
63. M.D. Jones I. Lucki Sex differences in the regulation of serotonergic transmission and behavior in 5-HT receptor knockout mice Neuropsychopharmacology 30 2005 1039 1047
64. D.A. Knobelman R. Hen I. Lucki Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse J. Pharmacol. Exp. Ther. 298 2001 1083 1091
65. W. Kostowski W. Dyr P. Krzascik T. Jarbe T. Archer 5-Hydroxytryptamine1A receptor agonists in animal models of depression and anxiety Pharmacol. Toxicol. 71 1992 24 30
66. B. Le Francois M. Czesak D. Steubl P.R. Albert Transcriptional regulation at a HTR1A polymorphism associated with mental illness Neuropharmacology 55 2008 977 985
67. M. Lekman S. Paddock F.J. McMahon Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial Mol. Diagn. Ther. 12 2008 321 330
68. K.P. Lesch Serotonergic gene expression and depression: implications for developing novel antidepressants J. Affect. Disord. 62 2001 57 76
69. K.P. Lesch D. Bengel A. Heils S.Z. Sabol B.D. Greenberg S. Petri J. Benjamin C.R. Muller D.H. Hamer D.L. Murphy Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region Science 274 1996 1527 1531
70. A.I. Leshner H. Remler A. Biegon D. Samuel Desmethylimipramine (DMI) counteracts learned helplessness in rats Psychopharmacology (Berl.) 66 1979 207 208
71. E. Lin P.S. Chen Pharmacogenomics with antidepressants in the STAR*D study Pharmacogenomics 9 2008 935 946
72. A. Lira M. Zhou N. Castanon M.S. Ansorge J.A. Gordon J.H. Francis M. Bradley-Moore J. Lira M.D. Underwood V. Arango H.F. Kung M.A. Hofer R. Hen J.A. Gingrich Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice Biol. Psychiatry 54 2003 960 971
73. G. Lucas V.V. Rymar J. Du O. Mnie-Filali C. Bisgaard S. Manta L. Lambas-Senas O. Wiborg N. Haddjeri G. Piñeyro A.F. Sadikot G. Debonnel Serotonin(4) (5-HT(4)) receptor agonists are putative antidepressants with a rapid onset of action Neuron 55 2007 712 725
74. I. Lucki A. Singh D.S. Kreiss Antidepressant-like behavioral effects of serotonin receptor agonists Neurosci. Biobehav. Rev. 18 1994 85 95
75. C.P. MacSweeney M. Lesourd J.M. Gandon Antidepressant-like effects of alnespirone (S 20499) in the learned helplessness test in rats Eur. J. Pharmacol. 345 1998 133 137
76. M. Maes H.Y. Meltzer The Serotonin Hypothesis of Major Depression 1995 Raven Press New York
77. M. Maes M.P. Jacobs E. Suy B. Minner C. Leclercq F. Christiaens J. Raus Suppressant effects of dexamethasone on the availability of plasma L-tryptophan and tyrosine in healthy controls and in depressed patients Acta Psychiatr. Scand. 81 1990 19 23
78. R. Mahesh R. Rajkumar B. Minasri R. Venkatesha Perumal Potential antidepressants: pharmacology of 2-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models Pharmazie 62 2007 919 924
79. G.J. Marek L.L. Carpenter C.J. McDougle L.H. Price Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders Neuropsychopharmacology 28 2003 402 412
80. 2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine Neuropsychopharmacology 30 2005 2205 2215
81. 3 receptor antagonists reverse helpless behaviour in rats Eur. J. Pharmacol. 212 1992 73 78
82. T. Matsuda P. Somboonthum M. Suzuki S. Asano A. Baba Antidepressant-like effect by postsynaptic 5-HT1A receptor activation in mice Eur. J. Pharmacol. 280 1995 235 238
83. A.J. Mayorga A. Dalvi M.E. Page S. Zimov-Levinson R. Hen I. Lucki Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice J. Pharmacol. Exp. Ther. 298 2001 1101 1107
84. F.J. McMahon S. Buervenich D. Charney R. Lipsky A.J. Rush A.F. Wilson A.J. Sorant G.J. Papanicolaou G. Laje M. Fava M.H. Trivedi S.R. Wisniewski H. Manji Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment Am. J. Hum. Genet. 78 2006 804 814
85. J.H. Meyer Imaging the serotonin transporter during major depressive disorder and antidepressant treatment J. Psychiatry Neurosci. 32 2007 86 102
86. J.H. Meyer S. McMain S.H. Kennedy L. Korman G.M. Brown J.N. DaSilva A.A. Wilson T. Blak R. Eynan-Harvey V.S. Goulding S. Houle P. Links Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm Am. J. Psychiatry 160 2003 90 99
87. F.A. Moreno A.J. Gelenberg G.R. Heninger R.L. Potter K.M. McKnight J. Allen A.P. Phillips P.L. Delgado Tryptophan depletion and depressive vulnerability Biol. Psychiatry 46 1999 498 505
88. Y. Nakagawa T. Ishima T. Takashima The 5-HT3 receptor agonist attenuates the action of antidepressants in the forced swim test in rats Brain Res. 786 1998 189 193
89. 1B mRNA in a sequential manner in the rat dorsal raphe nucleus Neuropsychopharmacology 15 1996 515 522
90. J.F. Neumaier F. Petty G.L. Kramer P. Szot M.W. Hamblin Learned helplessness increases 5-hydroxytryptamine1B receptor mRNA levels in the rat dorsal raphe nucleus Biol. Psychiatry 41 1997 668 674
91. A. Neumeister A.C. Nugent T. Waldeck M. Geraci M. Schwarz O. Bonne E.E. Bain D.A. Luckenbaugh P. Herscovitch D.S. Charney W.C. Drevets Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls Arch. Gen. Psychiatry 61 2004 765 773
92. O.F. O'Leary A.J. Bechtholt J.J. Crowley T.E. Hill M.E. Page I. Lucki Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test Psychopharmacology (Berl.) 192 2007 357 371
93. M.E. Page M.J. Detke A. Dalvi L.G. Kirby I. Lucki Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test Psychopharmacology (Berl.) 147 1999 162 167
94. C.L. Parks P.S. Robinson E. Sibille T. Shenk M. Toth Increased anxiety of mice lacking the serotonin1A receptor Proc. Natl. Acad. Sci. USA 95 1998 10734 10739
95. J.G. Patel G.D. Bartoszyk E. Edwards C.R. Ashby Jr. The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test Synapse 52 2004 73 75
96. E.A. Pehek C. Nocjar B.L. Roth T.A. Byrd O.S. Mabrouk Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex Neuropsychopharmacology 31 2006 265 277
97. G. Piñeyro P. Blier Autoregulation of serotonin neurons: role in antidepressant drug action Pharmacol. Rev. 51 1999 533 591
98. G.P. Placidi M.A. Oquendo K.M. Malone Y.Y. Huang S.P. Ellis J.J. Mann Aggressivity, suicide attempts, and depression: relationship to cerebrospinal fluid monoamine metabolite levels Biol. Psychiatry 50 2001 783 791
99. R.D. Porsolt M. Le Pichon M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
100. R.D. Porsolt A. Bertin M. Jalfre ‘Behavioural despair’ in rats and mice: strain differences and the effects of imipramine Eur. J. Pharmacol. 51 1978 291 294
101. E. Przegalinski E. Moryl M. Papp The effect of 5-HT1A receptor ligands in a chronic mild stress model of depression Neuropharmacology 34 1995 1305 1310
102. R. Ramamoorthy M. Radhakrishnan M. Borah Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models Behav. Pharmacol. 19 2008 29 40
103. J.P. Redrobe M. Bourin Partial role of 5-HT2 and 5-HT3 receptors in the activity of antidepressants in the mouse forced swimming test Eur. J. Pharmacol. 325 1997 129 135
104. S. Rosenzweig-Lipson A. Sabb G. Stack P. Mitchell I. Lucki J.E. Malberg S. Grauer J. Brennan J.F. Cryan S.J. Sukoff Rizzo J. Dunlop J.E. Barrett K.L. Marquis Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents Psychopharmacology (Berl.) 192 2007 159 170
105. L. Santarelli M. Saxe C. Gross A. Surget F. Battaglia S. Dulawa N. Weisstaub J. Lee R. Duman O. Arancio C. Belzung R. Hen Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants Science 301 2003 805 809
106. K.V. Savelieva S. Zhao V.M. Pogorelov I. Rajan Q. Yang E. Cullinan T.H. Lanthorn Genetic disruption of both tryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive to antidepressants PLoS ONE 3 2008 e3301
107. L.E. Schechter Q. Lin D.L. Smith G. Zhang Q. Shan B. Platt M.R. Brandt L.A. Dawson D. Cole R. Bernotas A. Robichaud S. Rosenzweig-Lipson C.E. Beyer Neuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466 Neuropsychopharmacology 33 2008 1323 1335
108. J.L. Scruggs D. Schmidt A.Y. Deutch The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats Neurosci. Lett. 346 2003 137 140
109. M.E. Seligman R.A. Rosellini M.J. Kozak Learned helplessness in the rat: time course, immunization, and reversibility J. Comp. Physiol. Psychol. 88 1975 542 547
110. A. Serretti P. Artioli The pharmacogenomics of selective serotonin reuptake inhibitors Pharmacogenomics J. 4 2004 233 244
111. C. Shen H. Li E. Meller Repeated treatment with antidepressants differentially alters 5-HT1A agonist-stimulated [35S]GTP gamma S binding in rat brain regions Neuropharmacology 42 2002 1031 1038
112. A.D. Sherman F. Petty Neurochemical basis of the action of antidepressants on learned helplessness Behav. Neural Biol. 30 1980 119 134
113. A. Singh I. Lucki Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors Neuropharmacology 32 1993 331 340
114. M. Smriga K. Torii L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats Proc. Natl. Acad. Sci. USA 100 2003 15370 15375
115. C. Song B.E. Leonard The olfactory bulbectomised rat as a model of depression Neurosci. Biobehav. Rev. 29 2005 627 647
116. L. Steru R. Chermat B. Thierry P. Simon The tail suspension test: a new method for screening antidepressants in mice Psychopharmacology (Berl.) 85 1985 367 370
117. C.A. Stockmeier Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter J. Psychiatr. Res. 37 2003 357 373
118. Stout, S.C., Owens, M.J. and Nemeroff, C.B. (1996) CRF1 receptor binding, mRNA expression and signal transduction after chronic antidepressant treatment in rats. In: Society for Neuroscience Annual Meeting.
119. P. Svenningsson K. Chergui I. Rachleff M. Flajolet X. Zhang M. El Yacoubi J.M. Vaugeois G.G. Nomikos P. Greengard Alterations in 5-HT1B receptor function by p11 in depression-like states Science 311 2006 77 80
120. P. Svenningsson E.T. Tzavara H. Qi R. Carruthers J.M. Witkin G.G. Nomikos P. Greengard Biochemical and behavioral evidence for antidepressant-like effects of 5-HT6 receptor stimulation J. Neurosci. 27 2007 4201 4209
121. E. Tatarczynska A. Klodzinska K. Stachowicz E. Chojnacka-Wojcik Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test Eur. J. Pharmacol. 487 2004 133 142
122. R.M. Tordera A. Monge J. Del Rio B. Lasheras Antidepressant-like activity of VN2222, a serotonin reuptake inhibitor with high affinity at 5-HT1A receptors Eur. J. Pharmacol. 442 2002 63 71
123. A. Van Den Bogaert S. De Zutter L. Heyrman J. Mendlewicz R. Adolfsson C. Van Broeckhoven J. Del-Favero Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 Neuron 48: 704; author reply 705-706
124. A. Wesolowska A. Nikiforuk K. Stachowicz E. Tatarczynska Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression Neuropharmacology 51 2006 578 586
125. A. Wesolowska A. Nikiforuk Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression Neuropharmacology 52 2007 1274 1283
126. A. Wesolowska A. Nikiforuk K. Stachowicz Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats Behav. Pharmacol. 18 2007 439 446
127. P. Willner Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation Psychopharmacology (Berl.) 134 1997 319 329
128. P. Willner Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS Neuropsychobiology 52 2005 90 110
129. X. Zhang R.R. Gainetdinov J.M. Beaulieu T.D. Sotnikova L.H. Burch R.B. Williams D.A. Schwartz K.R. Krishnan M.G. Caron Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16
130. Z. Zhou E.J. Peters S.P. Hamilton F. McMahon C. Thomas P.J. McGrath J. Rush M.H. Trivedi D.S. Charney A. Roy S. Wisniewski R. Lipsky D. Goldman Response to Zhang et al. (2005): loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression Neuron 45 2005 11 16 Neuron 48: 702-703; author reply 705-706
131. X. Zhuang C. Gross L. Santarelli V. Compan A.C. Trillat R. Hen Altered emotional states in knockout mice lacking 5-HT1A or 5-HT1B receptors Neuropsychopharmacology 21 1999 52S 60S